Yongin-si, South Korea

Eui-Cheol Jo

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Eui-Cheol Jo: Innovator in Biotechnology

Introduction

Eui-Cheol Jo is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, holding a total of eight patents. His work focuses on developing innovative therapeutic agents, particularly for hemophilia and gene therapy.

Latest Patents

Among his latest patents is a chimera protein comprising FVIII and vWF factors. This chimera protein has a significantly increased in vivo half-life when administered, enhancing patient convenience and reducing medical expenses for hemophilia A treatment. Another notable patent involves a hexon isolated from simian adenovirus serotype 19. This invention addresses safety and effective systemic treatment for developing gene therapeutic agents using adenovirus.

Career Highlights

Eui-Cheol Jo has worked with reputable organizations, including Mogam Biotechnology Research Institute and The Green Cross Corporation. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in biotechnology.

Collaborations

He has collaborated with notable colleagues, including Daekyung Koh and Seongtae Yun, to further enhance his research and development efforts.

Conclusion

Eui-Cheol Jo's innovative work in biotechnology, particularly in developing therapeutic agents, showcases his commitment to improving patient care and advancing medical science. His contributions continue to have a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…